BioEcosse 2010

CSO, BioReliance

New Methods for Detecting Adventitious Agents

Dr. Onions is responsible for leading BioReliance's global scientific efforts across preclinical and clinical activities, including the development of enhanced assay systems, consulting with key customers and partnering with regulatory agencies. Dr. Onions joined BioReliance from Invitrogen Corporation where he has held the role of Chief Medical Officer since 2005. Previously, Dr. Onions was a founder and director of Q-One Biotech Limited, a company well-known for its innovative biosafety testing and cGMP manufacturing services, headquartered in Glasgow, Scotland. Q-One Biotech was acquired by BioReliance in 2003, at which time Dr. Onions joined BioReliance as the company's Chief Scientific Officer.